Net profit of Beryl Drugs declined 20.59% to Rs 0.27 crore in the quarter ended September 2023 as against Rs 0.34 crore during the previous quarter ended September 2022. Sales rose 4.42% to Rs 8.03 crore in the quarter ended September 2023 as against Rs 7.69 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales8.037.69 4 OPM %8.978.06 - PBDT0.620.51 22 PBT0.330.32 3 NP0.270.34 -21 Powered by Capital Market - Live News

Beryl Drugs will hold a meeting of the Board of Directors of the Company on 8 November 2023.Powered by Capital Market - Live News

Beryl Drugs announced that the 30th Annual General Meeting (AGM) of the company will be held on 21 September 2023.Powered by Capital Market - Live News

Beryl Drugs will hold a meeting of the Board of Directors of the Company on 25 August 2023.Powered by Capital Market - Live News

Net profit of Beryl Drugs rose 140.91% to Rs 0.53 crore in the quarter ended June 2023 as against Rs 0.22 crore during the previous quarter ended June 2022. Sales rose 64.50% to Rs 8.11 crore in the quarter ended June 2023 as against Rs 4.93 crore during the previous quarter ended June 2022. ParticularsQuarter Ended�Jun. 2023Jun. 2022% Var. Sales8.114.93 65 OPM %13.9312.17 - PBDT1.010.47 115 PBT0.730.22 232 NP0.530.22 141 Powered by Capital Market - Live News